Ketoconazole (systemic) vs CYP2C19 Substrates

Interacting Drugs
Ketoconazole (systemic)
vs
CYP2C19 Substrates
Security Level
Minor, Monitor Therapy
Mechanism
CYP2C19 Substrates: CYP2C19 Inhibitors (Moderate) may decrease the metabolism of CYP2C19 Substrates.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ketoconazole (systemic) vs CYP2C19 Substrates


Other Interactions of Ketoconazole (systemic)

We are Developing Our database, More results coming soon.